Stevanato Group S.p.A. (NYSE:STVN) Stock Position Reduced by Deutsche Bank AG

Deutsche Bank AG trimmed its position in Stevanato Group S.p.A. (NYSE:STVN) by 20.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 989,661 shares of the company’s stock after selling 255,952 shares during the quarter. Deutsche Bank AG’s holdings in Stevanato Group were worth $21,565,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. First Bank & Trust increased its stake in Stevanato Group by 7.3% during the fourth quarter. First Bank & Trust now owns 15,145 shares of the company’s stock valued at $330,000 after purchasing an additional 1,036 shares during the last quarter. Truist Financial Corp boosted its holdings in shares of Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock valued at $586,000 after buying an additional 1,073 shares during the period. Oppenheimer Asset Management Inc. grew its position in shares of Stevanato Group by 9.7% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company’s stock valued at $281,000 after buying an additional 1,141 shares during the last quarter. US Bancorp DE raised its stake in Stevanato Group by 17.9% during the fourth quarter. US Bancorp DE now owns 8,527 shares of the company’s stock worth $186,000 after acquiring an additional 1,295 shares during the period. Finally, Advisors Capital Management LLC lifted its holdings in Stevanato Group by 1.0% in the fourth quarter. Advisors Capital Management LLC now owns 170,776 shares of the company’s stock worth $3,721,000 after acquiring an additional 1,735 shares during the last quarter.

Stevanato Group Stock Performance

STVN opened at €23.76 ($26.70) on Thursday. The business’s 50 day moving average is €21.34 and its 200-day moving average is €21.12. The stock has a market cap of $7.20 billion, a PE ratio of 50.55, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.61) and a twelve month high of €24.96 ($28.04).

Stevanato Group (NYSE:STVN) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, meeting the consensus estimate of €0.20 ($0.22). The firm had revenue of €352.68 million for the quarter, compared to analysts’ expectations of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. On average, analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Stevanato Group Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be issued a dividend of $0.0613 per share. This represents a dividend yield of 0.3%. This is a positive change from Stevanato Group’s previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th. Stevanato Group’s dividend payout ratio (DPR) is 11.76%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on STVN. UBS Group dropped their price target on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research report on Friday, March 7th. Stephens upgraded Stevanato Group to a “strong-buy” rating in a research note on Monday, April 21st. Finally, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Stevanato Group presently has an average rating of “Moderate Buy” and a consensus price target of €25.70 ($28.88).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.